Landscapes / Companies
Phathom Pharmaceuticals, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 3 in all
Trials
2 active
14 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | 20 Oct 2027Phase 3 trial completes | |||
| Next date | 20 Oct 2027 · Phase 3 trial completes | ||||
| Also tested for | Eosinophilic Esophagitis, Symptomatic Non-erosive Gastroesophageal Reflux Disease | ||||
| Open drug page | |||||
About
- No active trial
- Vonoprazan ODT-1 or ODT-2, Vonoprazan ODT-1 or ODT-2 without Water
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021